A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
Recruiting · NCT06995573 · Registry updated 2026-04-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 1 / Phase 2 | 2026-04-17 | NCT06995573 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NeuroScios GmbH | 1 |
| NSC-Therapeutics | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinic Altenburger Land GmbH | Altenburg | Germany | 1 |
| Dynamikos GmbH Institut fuer Studien zur Psychischen Gesundheit | Mannheim | Germany | 1 |
| Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft GmbH | Salzburg | Austria | 1 |
| Medical University Innsbruck | Innsbruck | Austria | 7 |
| Medical University Vienna | Vienna | Austria | 13 |
| Sanos Clinic | Ratingen | Germany | 2 |
| Universitaetsmedizin Goettingen | Göttingen | Germany | 10 |
| University Clinic Köln | Cologne | Germany | 1 |
| University Hospital Graz | Graz | Austria | 1 |
| Zentrum fuer klinische Forschung Dr. I. Schoell GmbH | Bad Homburg | Germany | 1 |